1
00:00:00,000 --> 00:00:05,083
Selank has been studied in people, but study design still matters.

2
00:00:05,083 --> 00:00:10,542
One 2008 report compared it with medazepam in patients with anxiety-related diagnoses.

3
00:00:10,542 --> 00:00:16,000
The report included sixty-two patients and described similar anxiety improvements between groups.

4
00:00:16,000 --> 00:00:21,458
An active-comparator result alone does not establish broad effectiveness or formal equivalence.

5
00:00:21,458 --> 00:00:26,125
The indexed abstract gives limited detail about methods and uncertainty.

6
00:00:26,125 --> 00:00:31,583
Larger, well-described trials and safety follow-up are needed to support stronger conclusions.

7
00:00:31,583 --> 00:00:37,042
FDA separately notes missing safety information and possible immune-reaction concerns for compounded

8
00:00:37,042 --> 00:00:43,292
Selank acetate. The clinical report should not be read as a guarantee of safety.